Franco Valle
Principal Accounting Officer, Iovance Biotherapeutics.
Companies
- Biomea Fusion, Inc.Chief financial officer Aug 5, 2021 to Dec 2, 20241
- Iovance BiotherapeuticsPrincipal Accounting Officer Apr 3, 2017 to Apr 3, 20172
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Biomea Fusion, Inc. BMEA42,995 shares3$37.4K at $0.87Nov 30, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 30, 2024Granted 495 shares at $6.15 of Biomea Fusion, Inc.3
- Jun 11, 2024Bought 12,509 shares at $4.43 of Biomea Fusion, Inc.4
- May 31, 2024Granted 4,448 shares at $3.78 of Biomea Fusion, Inc.4
- Nov 30, 2023Granted 1,345 shares at $3.78 of Biomea Fusion, Inc.5
- May 31, 2023Granted 4,273 shares at $3.78 of Biomea Fusion, Inc.6
- Nov 30, 2022Granted 2,518 shares at $3.78 of Biomea Fusion, Inc.7
- Nov 11, 2022Bought 4,100 shares at $7.63 of Biomea Fusion, Inc.8
- May 31, 2022Granted 3,307 shares at $4.67 of Biomea Fusion, Inc.9
- Jan 14, 2022Bought 10,000 shares at $8.68 of Biomea Fusion, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jun 12, 2024
- 5SEC EDGARForm 4 filed Dec 1, 2023
- 6SEC EDGARForm 4 filed Jun 2, 2023
- 7SEC EDGARForm 4 filed Dec 2, 2022
- 8SEC EDGARForm 4 filed Nov 14, 2022
- 9SEC EDGARForm 4 filed Jun 1, 2022
- 10SEC EDGARForm 4 filed Jan 18, 2022